299 related articles for article (PubMed ID: 22585231)
1. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
2. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma.
Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF
Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141
[TBL] [Abstract][Full Text] [Related]
3. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
[TBL] [Abstract][Full Text] [Related]
4. ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.
Yun M; Bai HY; Zhang JX; Rong J; Weng HW; Zheng ZS; Xu Y; Tong ZT; Huang XX; Liao YJ; Mai SJ; Ye S; Xie D
PLoS One; 2015; 10(2):e0117375. PubMed ID: 25714809
[TBL] [Abstract][Full Text] [Related]
5. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
[TBL] [Abstract][Full Text] [Related]
6. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer.
Zhang HY; Ma YD; Zhang Y; Cui J; Wang ZM
J Clin Pathol; 2017 May; 70(5):383-389. PubMed ID: 27679555
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HOXD13 expression in human breast cancer.
Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
[TBL] [Abstract][Full Text] [Related]
10. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
Choi J; Jung W; Koo JS
Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
Maae E; Olsen DA; Steffensen KD; Jakobsen EH; Brandslund I; Sørensen FB; Jakobsen A
Breast Cancer Res Treat; 2012 May; 133(1):257-65. PubMed ID: 22270936
[TBL] [Abstract][Full Text] [Related]
12. Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle.
Møller AB; Vendelbo MH; Christensen B; Clasen BF; Bak AM; Jørgensen JO; Møller N; Jessen N
J Appl Physiol (1985); 2015 Apr; 118(8):971-9. PubMed ID: 25678702
[TBL] [Abstract][Full Text] [Related]
13. Expression of XB130 in human ductal breast cancer.
Li J; Sun W; Wei H; Wang X; Li H; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231
[TBL] [Abstract][Full Text] [Related]
14. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
15. UNC-51-like kinase 1 expression in radical nephrectomy specimens as a predicting factor of progression-free survival in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors.
Nishikawa M; Miyake H; Bing L; Fujisawa M
Urol Oncol; 2015 Dec; 33(12):506.e1-7. PubMed ID: 26299883
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients.
Kim MH; Koo JS; Lee S
Oncology; 2013; 85(2):128-36. PubMed ID: 23948758
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.
Schmitz KJ; Ademi C; Bertram S; Schmid KW; Baba HA
World J Surg Oncol; 2016 Jul; 14(1):189. PubMed ID: 27444698
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
19. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells.
Aryal P; Kim K; Park PH; Ham S; Cho J; Song K
FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405
[TBL] [Abstract][Full Text] [Related]
20. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]